Abstract
Investigation of transcription factor activity in animal tissue during the early stage of cancer development can be difficult because of a low number of affected cells in a background of a large number of normal cells. We have used a well-established multistage skin carcinogenesis model to study the effect of manganese superoxide dismutase on the activity of AP-1 during an early stage of mouse skin carcinogenesis. The DNA binding activity of AP-1 proteins to a concensus DNA regulatory binding element known as TRE (TPA Responsive Element) is used as an in vitro assay for AP-1 activity in the nucleus of skin cells. This activity is detected by electrophoretic mobility shift assay (EMSA) which is based on the ability of specific proteins to bind and retard the migration of radioactive labeled oligonucleotides on a native gel. The presence of a specific protein in the complex can be identified by adding to EMSA an antibody specific for that protein, which will result in supershift complexes on the gel. The presence of the proteins in question can be further verified by standard Western analysis of the nuclear proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weisiger, R. A. and Fridovich, I. (1973) Superoxide dismutase: Organelle specificity. J. Biol. Chem. 248, 4793–4796.
Halliwell, B., Zhao, K., and Whiteman, M. (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res. 31(6), 651–669.
McCord, J. M. and Fridovich, I. (1988) Superoxide dismutase: the first twenty years (1968–1988). Free Radic. Biol. Med. 5(5–6), 363–369.
Oberley, L. W. and Buettner, G. R. (1979) Role of superoxide dismutase in cancer: a review. Cancer Res. 39, 1141–1149.
Sun, Y. (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 8, 583–599.
St. Clair, D. K. (1996) Tumor suppression by manganese superoxide dismutase: A novel function of MnSOD? A commentary. Oncol. Rep. 3, 429–432.
Kiningham, K. K. and St. Clair, D. K. (1997) Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res. 57, 5265–5271.
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., and Agrawal, B. B. (1998) Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor κB and activated protein-1. J. Biol. Chem. 273, 13,245–13,254.
Zhao, Y., Kiningham, K. K., Lin, S.-M., and St. Clair, D. K. (2001) Overexpression of MnSOD prevents murine fibrosarcoma (FsaII) cells from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: Involvement of MARK and NF-kB pathways. Antioxidants Redox Signal. 3, 375–385.
Zhao, Y., Xue, Y., Oberley, T. D., Kiningham, K. K., Lin, S.-M., Yen, H. C., et al. (2001) Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 61, 6082–6088.
Fischer, S. M., Jasheway, D. W., Klann, R. C., Butler, A. P., Patrick, K. E., Baldwin, J. K., and Cameron, G. S. (1989) Correlation of phobol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. Cancer Res. 49, 6693–6699.
Iversen, O. H. (1995) Of mice and men: a critical reappraisal of the two-stage theory of carcinogenesis. Crit. Rev. Oncology 6, 357–405.
Troll, W. (1991) Prevention of cancer by agents that suppress oxygen radical formation. Free Radic. Res. Commun. 12–13, 751–757.
Slaga, T. J. (1995) Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 369, 1671–1674.
Kouzarides, T. and Ziff, E. (1988) The role of the leucine zipper in the Fos-Jun interaction. Nature 336, 646–651.
Gopalakrishna, R. and Anderson, W. B. (1989) Ca2+-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA 86, 6758–6762.
Nishizuka, Y. (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661–665.
Palumbo, E. J., Sweatt, J. D., Chen, S.-J., and Klann, E. (1992) Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem. Biophys. Res. Comm. 187, 1439–1445.
McSwine-Kennick, R. L., McKeegan, E. M., Johnson, M. D., and Morin, M. J. (1991) Phorbol diester-induced alterations in the expression of protein kinase C isozymes and their mRNAs. J. Biol. Chem. 266, 15,135–15,143.
Verma, A. K., Pong, R. C., and Erickson, D. (1986) Involvement of protein kinaseC activation in ornitine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphor-bol-13 acetate. Cancer Res. 46, 6149–6155.
Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16,483–16,486.
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., and St. Clair, D. K. (1996) The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98, 1253–1260.
Ibrahim, H., Lee, U.-S., Yen, H. C., St. Clair, D. K., and Chow, C. K. (2000) Antioxidant and oxidative status in tissues of managanese superoxide dismutase transgenic mice. Free Radic. Biol. Med. 28, 379–402.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Zhao, Y., St. Clair, D.K. (2003). Detection of the Content and Activity of the Transcription Factor AP-1 in a Multistage Skin Carcinogenesis Model. In: Terrian, D.M. (eds) Cancer Cell Signaling. Methods in Molecular Biology™, vol 218. Humana Press. https://doi.org/10.1385/1-59259-356-9:177
Download citation
DOI: https://doi.org/10.1385/1-59259-356-9:177
Publisher Name: Humana Press
Print ISBN: 978-1-58829-075-5
Online ISBN: 978-1-59259-356-9
eBook Packages: Springer Protocols